Startup, New England (UNC) Regional Finals
Ailis Tweed-Kent, CEO
Cocoon Biotech, Inc., was founded in 2013 to bring the freedom of living a healthy productive life to patients worldwide initially through treatments for arthritis. Cocoon Biotech’s platform technology is a biocompatible silk protein that can be injected into joints to provide effective long lasting pain relief and potentially delay the progression of disease. This platform will leverage several unique properties of the silk protein fibroin, including strength, lubrication, and biocompatibility. Our mission is to use this technology to significantly improve the treatment of osteoarthritis and other degenerative joint disorders. The osteoarthritis treatment gap alone is currently quite large and new approaches that address both symptoms and disease progression are an urgent need.